Covered recipient · General Payments record
KENNETH ARLIN MCVEY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$1,481.75
- Reported across 103 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $407.33 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $146.30 | 14 |
| Lilly USA, LLC | $40.80 | 2 |
| E.R. Squibb & Sons, L.L.C. | $38.16 | 2 |
| Acerta Pharma LLC | $32.38 | 2 |
| Novo Nordisk AS | $27.43 | 2 |
| DEXCOM, INC. | $22.88 | 1 |
| Phathom Pharmaceuticals, Inc. | $20.96 | 1 |
| Astellas Pharma US Inc | $18.80 | 1 |
| Axsome Therapeutics, Inc. | $16.11 | 1 |
| Amgen Inc. | $14.57 | 1 |
| GlaxoSmithKline, LLC. | $14.54 | 1 |
| PFIZER INC. | $14.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.01 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105011509 | CMS |
| ABBVIE INC. | $12.67 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105011511 | CMS |
| ABBVIE INC. | $19.29 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105011513 | CMS |
| ABBVIE INC. | $18.76 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105011515 | CMS |
| ABBVIE INC. | $11.54 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105011517 | CMS |
| ABBVIE INC. | $4.42 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105011519 | CMS |
| ABBVIE INC. | $2.87 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105011521 | CMS |
| ABBVIE INC. | $5.39 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105011523 | CMS |
| ABBVIE INC. | $1.14 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105011525 | CMS |
| ABBVIE INC. | $17.86 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105011527 | CMS |
| ABBVIE INC. | $5.59 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105011529 | CMS |
| ABBVIE INC. | $6.42 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105011531 | CMS |
| ABBVIE INC. | $8.64 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105011533 | CMS |
| ABBVIE INC. | $12.70 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105011535 | CMS |
| Amgen Inc. | $14.57 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117325613 | CMS |
| Astellas Pharma US Inc | $18.80 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139277090 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.09 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104271817 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.29 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105594743 | CMS |
| Axsome Therapeutics, Inc. | $16.11 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148296006 | CMS |
| Dexcom, Inc. | $22.88 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153313980 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.61 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101829905 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.55 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101829981 | CMS |
| GlaxoSmithKline, LLC. | $14.54 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116643458 | CMS |
| Lilly USA, LLC | $21.19 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135129050 | CMS |
| Lilly USA, LLC | $19.61 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135098472 | CMS |
| Novo Nordisk Inc | $13.76 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097013530 | CMS |
| Novo Nordisk Inc | $13.67 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097495849 | CMS |
| PFIZER INC. | $14.40 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131429886 | CMS |
| Phathom Pharmaceuticals, Inc. | $20.96 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151095521 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.